Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Venous Thromboembolism"" wg kryterium: Temat


Tytuł:
Unanswered questions in cancer-associated thrombosis.
Autorzy:
Sanfilippo KM; Division of Hematology, Washington University School of Medicine St. Louis, St. Louis, MO, USA.; Division of Hematology/Oncology, St. Louis Veterans Administration Medical Center, St. Louis, MO, USA.
Moik F; Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Vienna, Austria.; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Candeloro M; Department of Innovative Technologies in Medicine and Dentistry, University 'G. D'Annunzio', Chieti, Italy.
Ay C; Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Vienna, Austria.
Di Nisio M; Department of Medicine and Ageing Sciences, University 'G D'Annunzio', Chieti-Pescara, Italy.
Lee AYY; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.; Systemic Therapy, BC Cancer, Vancouver, BC, Canada.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2022 Sep; Vol. 198 (5), pp. 812-825. Date of Electronic Publication: 2022 May 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasms*/complications
Neoplasms*/drug therapy
Thrombosis*/chemically induced
Venous Thromboembolism*/drug therapy
Venous Thromboembolism*/etiology
Anticoagulants ; Blood Coagulation ; Hemorrhage/chemically induced ; Heparin, Low-Molecular-Weight/therapeutic use ; Humans
Czasopismo naukowe
Tytuł:
Recommendations for standardized definitions, clinical assessment, and future research in pediatric clinically unsuspected venous thromboembolism: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis.
Autorzy:
Betensky M; Department of Pediatrics, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Institute of Clinical and Translational Research, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
Kulkarni K; Department of Pediatrics, Division of Hematology-Oncology, IWK Health Centre, Halifax, NS, Canada.
Rizzi M; Pediatric Hematology/Oncology Unit, Department of Woman-Mother-Child, University Hospital CHUV, Lausanne, Switzerland.
Jones S; Department of Nursing, The University of Melbourne, Melbourne, Vic., Australia.; Department of Clinical Haematology, The Royal Children's Hospital, Melbourne, Vic., Australia.
Brandão LR; Division of Haematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Faustino EVS; Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.
Goldenberg NA; Institute of Clinical and Translational Research, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.; Department of Medicine and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sharathkumar A; Stead Family Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Pokaż więcej
Źródło:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Jul; Vol. 20 (7), pp. 1729-1734. Date of Electronic Publication: 2022 May 15.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Thrombosis*/complications
Venous Thromboembolism*/diagnosis
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Anticoagulants/therapeutic use ; Child ; Communication ; Hemostasis ; Humans ; Infant, Newborn
Czasopismo naukowe
Tytuł:
Alert-Triggered Patient Education Versus Nurse Feedback for Nonadministered Venous Thromboembolism Prophylaxis Doses: A Cluster-Randomized Controlled Trial.
Autorzy:
Haut ER; Department of Surgery Johns Hopkins University School of Medicine Baltimore MD.; Department of Anesthesiology and Critical Care Medicine Johns Hopkins University School of Medicine Baltimore MD.; Department of Emergency Medicine Johns Hopkins University School of Medicine Baltimore MD.; The Johns Hopkins Surgery Center for Outcomes Research Johns Hopkins University School of Medicine Baltimore MD.; Armstrong Institute for Patient Safety and Quality Johns Hopkins Medicine Baltimore MD.; Department of Health Policy and Management Johns Hopkins Bloomberg School of Public Health Baltimore MD.
Owodunni OP; Department of Surgery Johns Hopkins University School of Medicine Baltimore MD.
Wang J; Department of Biostatistics Johns Hopkins Bloomberg School of Public Health Baltimore MD.
Shaffer DL; Department of Surgery Johns Hopkins University School of Medicine Baltimore MD.; Department of Nursing The Johns Hopkins Hospital Baltimore MD.
Hobson DB; Department of Surgery Johns Hopkins University School of Medicine Baltimore MD.; Armstrong Institute for Patient Safety and Quality Johns Hopkins Medicine Baltimore MD.; Department of Nursing The Johns Hopkins Hospital Baltimore MD.
Yenokyan G; Department of Biostatistics Johns Hopkins Bloomberg School of Public Health Baltimore MD.
Kraus PS; Department of Pharmacy The Johns Hopkins Hospital Baltimore MD.
Farrow NE; Department of Surgery Duke University Medical Center Durham NC.
Canner JK; The Johns Hopkins Surgery Center for Outcomes Research Johns Hopkins University School of Medicine Baltimore MD.
Florecki KL; Department of Surgery Johns Hopkins University School of Medicine Baltimore MD.
Webster KLW; Department of Anesthesiology and Critical Care Medicine Johns Hopkins University School of Medicine Baltimore MD.
Holzmueller CG; Department of Surgery Johns Hopkins University School of Medicine Baltimore MD.; Armstrong Institute for Patient Safety and Quality Johns Hopkins Medicine Baltimore MD.
Aboagye JK; Department of Surgery Johns Hopkins University School of Medicine Baltimore MD.
Popoola VO; Department of Biostatistics Johns Hopkins Bloomberg School of Public Health Baltimore MD.; Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD.
Kia MV; Department of Surgery Johns Hopkins University School of Medicine Baltimore MD.
Pronovost PJ; Department of Surgery Johns Hopkins University School of Medicine Baltimore MD.; Armstrong Institute for Patient Safety and Quality Johns Hopkins Medicine Baltimore MD.; Department of Health Policy and Management Johns Hopkins Bloomberg School of Public Health Baltimore MD.
Streiff MB; Division of Hematology, Department of Medicine Johns Hopkins University School of Medicine Baltimore MD.; Armstrong Institute for Patient Safety and Quality Johns Hopkins Medicine Baltimore MD.
Lau BD; Division of Health Sciences Informatics, Russell H. Morgan Department of Radiology and Radiological Science Johns Hopkins University School of Medicine Baltimore MD.; Armstrong Institute for Patient Safety and Quality Johns Hopkins Medicine Baltimore MD.; Department of Health Policy and Management Johns Hopkins Bloomberg School of Public Health Baltimore MD.
Pokaż więcej
Źródło:
Journal of the American Heart Association [J Am Heart Assoc] 2022 Sep 20; Vol. 11 (18), pp. e027119. Date of Electronic Publication: 2022 Sep 01.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Venous Thromboembolism*/diagnosis
Venous Thromboembolism*/drug therapy
Venous Thromboembolism*/prevention & control
Adult ; Anticoagulants/adverse effects ; Feedback ; Hospitalization ; Humans ; Patient Education as Topic
Czasopismo naukowe
Tytuł:
Obesity as a Risk Factor for Venous Thromboembolism Recurrence: A Systematic Review.
Autorzy:
Ntinopoulou P; Department of Cardiology, Laikon General Hospital, 11527 Athens, Greece.
Ntinopoulou E; Department of Pediatrics, Yverdon-les-Bains Hospital, 1400 Yverdon-les-Bains, Switzerland.
Papathanasiou IV; Community Nursing Lab, Faculty of Nursing, University of Thessaly, 41500 Larissa, Greece.
Fradelos EC; Community Nursing Lab, Faculty of Nursing, University of Thessaly, 41500 Larissa, Greece.
Kotsiou O; Faculty of Nursing, School of Health Sciences, University of Thessaly, 41500 Larissa, Greece.
Roussas N; Department of Vascular Surgery, Faculty of Medicine, University Hospital of Larissa, University of Thessaly, 41500 Larissa, Greece.
Raptis DG; Respiratory Disorders Lab, Faculty of Nursing, University of Thessaly, 41500 Larissa, Greece.
Gourgoulianis KI; Respiratory Medicine Department, Faculty of Medicine, University Hospital of Larissa, University of Thessaly, 41500 Larissa, Greece.
Malli F; Respiratory Disorders Lab, Faculty of Nursing, University of Thessaly, 41500 Larissa, Greece.; Respiratory Medicine Department, Faculty of Medicine, University Hospital of Larissa, University of Thessaly, 41500 Larissa, Greece.
Pokaż więcej
Źródło:
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2022 Sep 16; Vol. 58 (9). Date of Electronic Publication: 2022 Sep 16.
Typ publikacji:
Journal Article; Review; Systematic Review
MeSH Terms:
Pulmonary Embolism*/complications
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Adult ; Anticoagulants/therapeutic use ; Cross-Sectional Studies ; Female ; Humans ; Obesity/complications ; Prospective Studies ; Randomized Controlled Trials as Topic ; Recurrence ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł:
Outcome of anticoagulation with rivaroxaban in patients with non-retrieved inferior vena cava filters for the prevention of filter thrombosis: a retrospective cohort study.
Autorzy:
Wang B; Department of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Jiang C; Department of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Zhang Y; Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Li X; Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Xu H; Department of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China. .
Pokaż więcej
Źródło:
BMC cardiovascular disorders [BMC Cardiovasc Disord] 2022 Sep 11; Vol. 22 (1), pp. 406. Date of Electronic Publication: 2022 Sep 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Thrombosis*/etiology
Vena Cava Filters*/adverse effects
Venous Thromboembolism*/diagnosis
Venous Thromboembolism*/etiology
Venous Thromboembolism*/prevention & control
Anticoagulants/adverse effects ; Humans ; Retrospective Studies ; Rivaroxaban/adverse effects ; Warfarin
Czasopismo naukowe
Tytuł:
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.
Autorzy:
Dybowska M; Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.
Wyrostkiewicz D; Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.
Opoka L; Department of Radiology, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.
Lewandowska K; Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.
Sobiecka M; Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.
Tomkowski W; Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.
Szturmowicz M; Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Sep 08; Vol. 23 (18). Date of Electronic Publication: 2022 Sep 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*/complications
COVID-19*/drug therapy
Venous Thromboembolism*/drug therapy
Venous Thromboembolism*/etiology
Venous Thromboembolism*/prevention & control
Venous Thrombosis*/drug therapy
Anticoagulants/therapeutic use ; Heparin/therapeutic use ; Humans ; SARS-CoV-2
SCR Disease Name:
post-acute COVID-19 syndrome
Czasopismo naukowe
Tytuł:
Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner.
Autorzy:
Harrigan AM; Department of Medicine, Division of Hematology, Dalhousie University, Nova Scotia Health, Halifax, NS B3H 2Y9, Canada.
Rioux J; Department of Pharmacy, Nova Scotia Health, Victoria General Site, Halifax, NS B3H 2Y9, Canada.
Shivakumar S; Department of Medicine, Division of Hematology, Dalhousie University, Nova Scotia Health, Halifax, NS B3H 2Y9, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Sep 08; Vol. 29 (9), pp. 6419-6432. Date of Electronic Publication: 2022 Sep 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasms*/complications
Neoplasms*/drug therapy
Thrombosis*/drug therapy
Venous Thromboembolism*/drug therapy
Venous Thromboembolism*/etiology
Anticoagulants/therapeutic use ; Heparin, Low-Molecular-Weight/therapeutic use ; Humans
Czasopismo naukowe
Tytuł:
The ICU-venous thromboembolism score and tumor grade can predict inhospital venous thromboembolism occurrence in critical patients with tumors.
Autorzy:
Mei R; Department of Critical Care Medicine (ICU), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
Wang G; Department of Critical Care Medicine (ICU), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
Chen R; Department of Critical Care Medicine (ICU), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
Wang H; Department of Critical Care Medicine (ICU), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2022 Sep 05; Vol. 20 (1), pp. 245. Date of Electronic Publication: 2022 Sep 05.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms*/complications
Neoplasms*/therapy
Venous Thromboembolism*/diagnosis
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Aged ; Blood Component Transfusion ; Critical Illness/therapy ; Humans ; Intensive Care Units ; Plasma ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancer.
Autorzy:
Watson NW; Harvard Medical School, Boston, Massachusetts, USA.
Wander SA; Harvard Medical School, Boston, Massachusetts, USA.; Division of Hematology Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Shatzel JJ; Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA.; Division of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA.
Al-Samkari H; Harvard Medical School, Boston, Massachusetts, USA.; Division of Hematology Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Cancer [Cancer] 2022 Sep 01; Vol. 128 (17), pp. 3224-3232. Date of Electronic Publication: 2022 Jun 29.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Breast Neoplasms*/drug therapy
Thrombosis*/drug therapy
Venous Thromboembolism*/chemically induced
Venous Thromboembolism*/epidemiology
Aminopyridines ; Anticoagulants/therapeutic use ; Benzimidazoles ; Female ; Humans
Czasopismo naukowe
Tytuł:
Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis.
Autorzy:
El-Amin N; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, VA, USA.
Iness A; Schoold of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Cyrus JW; Health Sciences Library, VCU Libraries, Virginia Commonwealth University, Richmond, VA, USA.
Sisler I; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, VA, USA.
Karam O; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, 1250 E Marshall St., Richmond, VA, 23298, USA. .
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2022 Sep; Vol. 101 (9), pp. 1931-1940. Date of Electronic Publication: 2022 Jul 27.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Anemia, Sickle Cell*/complications
Anemia, Sickle Cell*/drug therapy
Venous Thromboembolism*/drug therapy
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Venous Thrombosis*/drug therapy
Venous Thrombosis*/etiology
Venous Thrombosis*/prevention & control
Anticoagulants/therapeutic use ; Hemorrhage/epidemiology ; Humans ; Recurrence
Czasopismo naukowe
Tytuł:
Obstetric venous thromboembolism: Evaluation of prophylactic approach based on risk scores, D-dimer levels, and ultrasonography findings in a tertiary hospital in Japan.
Autorzy:
Obata-Yasuoka M; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Ohara R; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Hosokawa Y; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Nishida K; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Abe H; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Mayumi M; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Ishizu T; Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Endo-Kawamura N; Department of Anesthesiology, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
Hamada H; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Satoh T; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Pokaż więcej
Źródło:
The journal of obstetrics and gynaecology research [J Obstet Gynaecol Res] 2022 Sep; Vol. 48 (9), pp. 2334-2344. Date of Electronic Publication: 2022 Jun 22.
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Embolism*/diagnostic imaging
Pulmonary Embolism*/prevention & control
Venous Thromboembolism*/diagnostic imaging
Venous Thromboembolism*/prevention & control
Venous Thrombosis*/diagnostic imaging
Venous Thrombosis*/prevention & control
Female ; Fibrin Fibrinogen Degradation Products ; Humans ; Infant, Newborn ; Japan/epidemiology ; Pregnancy ; Retrospective Studies ; Risk Factors ; Tertiary Care Centers ; Ultrasonography
Czasopismo naukowe
Tytuł:
Thromboprophylaxis of Patients Submitted to Total Hip and Knee Arthroplasty: A Cost-Effectiveness Assessment From the Perspective of the Brazilian National Health System.
Autorzy:
de Brito AFS; Federal University of Bahia (UFBA), Salvador, BA, Brazil; State Department of Health of the Federal District (SESDF), Brasília, DF, Brazil. Electronic address: .
Brito NC; Ministry of Health of Brazil (MS), Brasília, DF, Brazil.
Tanaka SKT; Market Access & Patient Engagement Solutions (MAPESolutions), São Paulo, SP, Brazil.
Ferreira VL; Market Access & Patient Engagement Solutions (MAPESolutions), São Paulo, SP, Brazil; Federal University of Paraná (UFPR), Curitiba, PR, Brazil.
Ferreira Júnior ABS; State Department of Health of the Federal District (SESDF), Brasília, DF, Brazil; Institute of Strategic Health Management of the Federal District (IGESDF), Brasília, DF, Brazil.
Riveros BS; Market Access & Patient Engagement Solutions (MAPESolutions), São Paulo, SP, Brazil; Federal University of Paraná (UFPR), Curitiba, PR, Brazil.
Nita ME; Market Access & Patient Engagement Solutions (MAPESolutions), São Paulo, SP, Brazil; University of São Paulo (USP), São Paulo, SP, Brazil.
Pokaż więcej
Źródło:
Value in health regional issues [Value Health Reg Issues] 2022 Sep; Vol. 31, pp. 111-118. Date of Electronic Publication: 2022 May 28.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Arthroplasty, Replacement, Hip*/adverse effects
Arthroplasty, Replacement, Knee*/adverse effects
Arthroplasty, Replacement, Knee*/methods
Venous Thromboembolism*/etiology
Venous Thromboembolism*/prevention & control
Anticoagulants/therapeutic use ; Brazil ; Cost-Benefit Analysis ; Dabigatran/therapeutic use ; Enoxaparin/adverse effects ; Humans ; Rivaroxaban/therapeutic use
Czasopismo naukowe
Tytuł:
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
Autorzy:
Guillo L; Department of Gastroenterology, University Hospital of Marseille Nord, University of Aix-Marseille, Chemin des Bourrely, 13015, Marseille, France. .
Amiot A; Department of Gastroenterology, Groupe Hospitalier Henri Mondor-Albert Chennevier, APHP, EC2M3-EA7375, University of Paris Est Créteil, Créteil, France.
Serrero M; Department of Gastroenterology, University Hospital of Marseille Nord, University of Aix-Marseille, Chemin des Bourrely, 13015, Marseille, France.
Altwegg R; Department of Gastroenterology, Saint-Eloi Hospital, University Hospital of Montpellier, Montpellier, France.
Roblin X; Department of Gastroenterology, Saint-Etienne University Hospital, Saint-Étienne, France.
Atanasiu C; Department of Gastroenterology, AP-HP, Hôpital Saint-Joseph, Paris, France.
Buisson A; Université Clermont Auvergne, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Inserm U1071, M2iSH, USC-INRA 2018, Clermont-Ferrand, France.
Le Berre C; Department of Gastroenterology, Institut des Maladies de L'Appareil Digestif (IMAD), CIC Inserm 1413, Nantes University Hospital, Nantes, France.
Reenaers C; Department of Gastroenterology, University Hospital of Liège, Liège, Belgium.
Gornet JM; Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Université de Paris, Paris, France.
Laharie D; CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie et oncologie digestive - Université de Bordeaux, 33000, Bordeaux, France.
Abitbol V; Department of Gastroenterology, Paris Descartes University, Sorbonne Paris Cité, Cochin Hospital, APHP, Paris, France.
Biron A; Department of Gastroenterology, Reims University Hospital, Reims, France.
Caron B; Department of Gastroenterology, Hautepierre Strasbourg University Hospital and INSERM U1113 IRFAC, University of Strasbourg, Strasbourg, France.
Nancey S; Department of Gastroenterology and Inserm U1111-CIRI, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre Bénite, France.
Chupin A; Department of Gastroenterology, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris and Université Paris Saclay, Le Kremlin-Bicêtre, France.
Blain A; Department of Gastroenterology, Institut Mutualiste Montsouris, Paris, France.
Vuitton L; Department of Gastroenterology, Besancon University Hospital, Besançon, France.
Caillo L; Department of Gastroenterology, University Hospital of Nimes, Nîmes, France.
Kirchgesner J; Department of Gastroenterology, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, Paris, France.
Nachury M; Univ, Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000, Lille, France.
Peyrin-Biroulet L; Department of Gastroenterology, Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Pokaż więcej
Corporate Authors:
FOCUS Study Group
Źródło:
Digestive diseases and sciences [Dig Dis Sci] 2022 Sep; Vol. 67 (9), pp. 4525-4532. Date of Electronic Publication: 2022 Mar 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiovascular Diseases*/complications
Cardiovascular Diseases*/diagnosis
Cardiovascular Diseases*/epidemiology
Colitis, Ulcerative*/complications
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/epidemiology
Venous Thromboembolism*/diagnosis
Venous Thromboembolism*/epidemiology
Adult ; Cross-Sectional Studies ; Female ; Humans ; Prevalence ; Risk Factors ; Self Report
Czasopismo naukowe
Tytuł:
Comparative effectiveness and safety of edoxaban, rivaroxaban, and apixaban in patients with venous thromboembolism: A cohort study.
Autorzy:
Fukasawa T; Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.; Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Seki T; Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Nakashima M; Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Kawakami K; Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Pokaż więcej
Źródło:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Sep; Vol. 20 (9), pp. 2083-2097. Date of Electronic Publication: 2022 Jul 07.
Typ publikacji:
Journal Article
MeSH Terms:
Rivaroxaban*/adverse effects
Venous Thromboembolism*/diagnosis
Venous Thromboembolism*/drug therapy
Venous Thromboembolism*/prevention & control
Anticoagulants/therapeutic use ; Cohort Studies ; Gastrointestinal Hemorrhage/chemically induced ; Gastrointestinal Hemorrhage/diagnosis ; Humans ; Intracranial Hemorrhages/chemically induced ; Intracranial Hemorrhages/drug therapy ; Pyrazoles ; Pyridines ; Pyridones/adverse effects ; Retrospective Studies ; Thiazoles
Czasopismo naukowe
Tytuł:
Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients.
Autorzy:
Ionescu F; Department of Internal Medicine, Beaumont Health System, OUWB School of Medicine, Royal Oak, Michigan, USA.; H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Anusim N; Department of Hematology and Oncology, Dell Medical School, University of Texas in Austin, Austin, Texas, USA.; Department of Hematology-Oncology, Beaumont Health System, OUWB School of Medicine, Royal Oak, Michigan, USA.
Zimmer M; Department of Internal Medicine, Beaumont Health System, OUWB School of Medicine, Royal Oak, Michigan, USA.
Jaiyesimi I; Department of Hematology-Oncology, Beaumont Health System, OUWB School of Medicine, Royal Oak, Michigan, USA.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2022 Sep; Vol. 109 (3), pp. 282-288. Date of Electronic Publication: 2022 Jun 08.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Anemia, Sickle Cell*/complications
Anemia, Sickle Cell*/drug therapy
Sickle Cell Trait*/complications
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Venous Thromboembolism*/prevention & control
Adult ; Anticoagulants/therapeutic use ; Hospitalization ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Extended anticoagulation for venous thromboembolism: A survey of the American Venous Forum and the European Venous Forum.
Autorzy:
Shaydakov ME; Department of Surgery, Central Michigan University College of Medicine, Saginaw, MI. Electronic address: .
Ting W; Icahn School of Medicine at Mount Sinai, New York, NY.
Sadek M; NYU Langone Health, New York, NY.
Aziz F; Penn State Heart and Vascular Institute, Hershey, PA.
Diaz JA; Vanderbilt University Medical Center, Nashville, TN.
Comerota AJ; Inova Heart and Vascular Institute, Falls Church, VA.
Lurie F; Jobst Vascular Institute, ProMedica Health System, Toledo, OH; Section of Vascular Surgery, University of Michigan, Ann Arbor, MI.
Blebea J; Department of Surgery, Central Michigan University College of Medicine, Saginaw, MI.
Eklöf BG; Lund University, Lund, Sweden.
Lugli M; International Center of Deep Venous Surgery, Hesperia Hospital, Modena, Italy.
De Maeseneer MGR; Department of Dermatology, Erasmus Medical Center, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Kakkos SK; Department of Vascular Surgery, University of Patras, Patras, Greece.
Nicolaides A; Vascular Screening and Diagnostic Centre, Nicosia, Cyprus.
Heim D; Department of Surgery, Clinic Hohmad, Thun, Switzerland.
Welch HJ; Vascular Care Group, Hyannis, MA.
Pokaż więcej
Corporate Authors:
American Venous Forum Research Committee
Źródło:
Journal of vascular surgery. Venous and lymphatic disorders [J Vasc Surg Venous Lymphat Disord] 2022 Sep; Vol. 10 (5), pp. 1012-1020.e3. Date of Electronic Publication: 2022 May 11.
Typ publikacji:
Journal Article
MeSH Terms:
Venous Thromboembolism*/diagnosis
Venous Thromboembolism*/drug therapy
Anticoagulants/therapeutic use ; Hemorrhage/chemically induced ; Hemorrhage/prevention & control ; Humans ; Surveys and Questionnaires ; Warfarin
Czasopismo naukowe
Tytuł:
Incidence, characteristics, and risk factors of venous thromboembolism in shoulder arthroplasty-a systematic review.
Autorzy:
Na SS; Department of Orthopedic Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu, 42601, South Korea.
Kim DH; Department of Orthopedic Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu, 42601, South Korea.
Choi BC; Department of Orthopedic Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu, 42601, South Korea.
Cho CH; Department of Orthopedic Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu, 42601, South Korea. .
Pokaż więcej
Źródło:
International orthopaedics [Int Orthop] 2022 Sep; Vol. 46 (9), pp. 2081-2088. Date of Electronic Publication: 2022 Jun 28.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Arthroplasty, Replacement, Shoulder*/adverse effects
Pulmonary Embolism*/etiology
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Venous Thromboembolism*/prevention & control
Venous Thrombosis*/epidemiology
Venous Thrombosis*/etiology
Venous Thrombosis*/prevention & control
Aged ; Anticoagulants/therapeutic use ; Arthroplasty/adverse effects ; Humans ; Incidence ; Risk Factors
Czasopismo naukowe
Tytuł:
New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism.
Autorzy:
Wumaier K; The First Hospital of Jilin University, Jilin University, Changchun, People's Republic of China.
Li W; The First Hospital of Jilin University, Jilin University, Changchun, People's Republic of China.
Cui J; Department of Cancer Center, the First Hospital of Jilin University, Changchun, People's Republic of China.
Pokaż więcej
Źródło:
Drug design, development and therapy [Drug Des Devel Ther] 2022 Aug 03; Vol. 16, pp. 2497-2507. Date of Electronic Publication: 2022 Aug 03 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasms*/complications
Neoplasms*/drug therapy
Venous Thromboembolism*/chemically induced
Venous Thromboembolism*/complications
Venous Thromboembolism*/drug therapy
Administration, Oral ; Anticoagulants ; Heparin, Low-Molecular-Weight/therapeutic use ; Humans ; Quality of Life
Czasopismo naukowe
Tytuł:
Association between bullous pemphigoid and risk of venous thromboembolism: A nationwide population-based cohort study.
Autorzy:
Chen CL; Department of Medical Education, National Taiwan University Hospital, Taipei, Taiwan.
Wu CY; Division of Translational Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan.; College of Public Health, China Medical University Taichung, Taiwan.
Lyu YS; Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chou YJ; Department of Public Health, Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chang YT; Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan.; Department of Dermatology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Wu CY; Department of Public Health, Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan.; Department of Dermatology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Pokaż więcej
Źródło:
The Journal of dermatology [J Dermatol] 2022 Aug; Vol. 49 (8), pp. 753-761. Date of Electronic Publication: 2022 May 02.
Typ publikacji:
Journal Article
MeSH Terms:
Pemphigoid, Bullous*/complications
Pemphigoid, Bullous*/epidemiology
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Cohort Studies ; Female ; Humans ; Incidence ; Risk Factors
Czasopismo naukowe
Tytuł:
Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial.
Autorzy:
Brandt W; Department of Medicine, University of Ottawa, the Ottawa Hospital Research Institute, Ottawa, Canada; Faculty of Science, University of Ottawa, Ottawa, Canada.
Brown C; Department of Medicine, University of Ottawa, the Ottawa Hospital Research Institute, Ottawa, Canada; Faculty of Arts and Science, Queen's University, Kingston, Canada.
Wang TF; Department of Medicine, University of Ottawa, the Ottawa Hospital Research Institute, Ottawa, Canada.
Tagalakis V; Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Quebec, Canada.
Shivakumar S; Department of Medicine, Dalhousie University, Nova Scotia Health, Halifax, Nova Scotia, Canada.
Ciuffini LA; Thrombosis and Haemorragic Diseases Unit, IRCCS Humanitas Research Hospital, 20089 Milan, Italy.
Mallick R; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Wells PS; Department of Medicine, University of Ottawa, the Ottawa Hospital Research Institute, Ottawa, Canada.
Carrier M; Department of Medicine, University of Ottawa, the Ottawa Hospital Research Institute, Ottawa, Canada. Electronic address: .
Pokaż więcej
Źródło:
Thrombosis research [Thromb Res] 2022 Aug; Vol. 216, pp. 8-10. Date of Electronic Publication: 2022 May 29.
Typ publikacji:
Letter; Randomized Controlled Trial
MeSH Terms:
Central Venous Catheters*/adverse effects
Neoplasms*/complications
Neoplasms*/drug therapy
Venous Thromboembolism*/drug therapy
Venous Thromboembolism*/etiology
Venous Thromboembolism*/prevention & control
Anticoagulants/therapeutic use ; Hemorrhage/complications ; Humans ; Primary Prevention ; Pyrazoles ; Pyridones/adverse effects
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz